BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7069591)

  • 21. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation of authentic and artifactual effect of circulating heparin on drug protein binding.
    Dubé LM; Davies RF; Beanlands DS; Mousseau N; Beaudoin N; Chan B; Ho-Ngoc A; McGilveray IJ
    Biopharm Drug Dispos; 1989; 10(1):55-68. PubMed ID: 2923961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein binding of warfarin: methodological considerations.
    Mungall D; Wong YY; Talbert RL; Crawford MH; Marshall J; Hawkins DW; Ludden TM
    J Pharm Sci; 1984 Jul; 73(7):1000-1. PubMed ID: 6470938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and clinical implications of quinidine protein binding.
    Woo E; Greenblatt DJ
    J Pharm Sci; 1979 Apr; 68(4):466-70. PubMed ID: 438971
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of assay procedures used to measure total and unbound concentrations of quinidine.
    Wooding-Scott RA; Darling IM; Slaughter RL
    DICP; 1989 Dec; 23(12):999-1004. PubMed ID: 2690475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability, blood partition, and protein binding of DA-5018, a new nonnarcotic analgesic.
    Shim HJ; Lee JJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):97-108. PubMed ID: 8824935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma.
    Trung AH; Sirois G; Dubé LM; McGilveray IJ
    Biopharm Drug Dispos; 1984; 5(3):281-90. PubMed ID: 6487754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative.
    Kim SH; Lee JS; Lee MG
    Biopharm Drug Dispos; 1999 Oct; 20(7):355-60. PubMed ID: 10760844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
    Moon YJ; Kim SH; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):167-77. PubMed ID: 11913709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.
    Nilsen OG; Fremstad D; Jacobsen S
    Eur J Pharmacol; 1975 Aug; 33(1):131-9. PubMed ID: 1175679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of renal transplantation on plasma protein binding.
    Affrime MB; Blecker DL; Lyons PJ; Pitone JM; Swartz CD; Lowenthal DT
    J Dial; 1979; 3(2-3):207-18. PubMed ID: 389974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios.
    Ho Ngoc-Ta Trung A; Sirois G
    Pharm Acta Helv; 1987; 62(2):61-4. PubMed ID: 3575343
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of disease on binding of drugs to plasma proteins.
    Reidenberg MM; Affrime M
    Ann N Y Acad Sci; 1973 Nov; 226():115-26. PubMed ID: 4520390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.